SYMBICORT® in the Treatment of COPD
SRP COPD
A Scientific Research Program to Evaluate the Efficacy of SYMBICORT® 320/9μg in the Treatment of COPD in Real Life Environment by General Practitioners
1 other identifier
observational
N/A
0 countries
N/A
Brief Summary
A Scientific Research Program to evaluate the efficacy of SYMBICORT® 320/9μg in the treatment of COPD in real life environment by General Practitioners
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Mar 2006
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2007
CompletedFirst Submitted
Initial submission to the registry
November 26, 2007
CompletedFirst Posted
Study publicly available on registry
November 28, 2007
CompletedJanuary 28, 2011
January 1, 2011
November 26, 2007
January 27, 2011
Conditions
Keywords
Eligibility Criteria
patients
You may qualify if:
- patients (m/f) with COPD (GOLD stadium III and IV)
You may not qualify if:
- patients who recently quit smoking (\<3months)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
E Louis, PR
Université Libre de Liège
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
November 26, 2007
First Posted
November 28, 2007
Study Start
March 1, 2006
Study Completion
May 1, 2007
Last Updated
January 28, 2011
Record last verified: 2011-01